Compare · ILMN vs TRUP
ILMN vs TRUP
Side-by-side comparison of Illumina Inc. (ILMN) and Trupanion Inc. (TRUP): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ILMN and TRUP operate in Medical Specialities (Health Care), so they compete in similar markets.
- ILMN is the larger of the two at $28.24B, about 24.2x TRUP ($1.16B).
- Over the past year, ILMN is up 94.2% and TRUP is down 47.8% - ILMN leads by 142.0 points.
- ILMN has been more active in the news (11 items in the past 4 weeks vs 4 for TRUP).
- ILMN has more recent analyst coverage (25 ratings vs 12 for TRUP).
- Company
- Illumina Inc.
- Trupanion Inc.
- Price
- $186.76-1.85%
- $26.71+1.44%
- Market cap
- $28.24B
- $1.16B
- 1M return
- +13.80%
- +9.42%
- 1Y return
- +94.24%
- -47.79%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- News (4w)
- 11
- 4
- Recent ratings
- 25
- 12
Illumina Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Trupanion Inc.
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Latest ILMN
- Illumina expands Billion Cell Atlas program with new AI drug developers
- Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
- Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer
- Director Meister Keith A. was granted 142 shares, increasing direct ownership by 2% to 6,780 units (SEC Form 4)
- Director Ullem Scott B. was granted 167 shares, increasing direct ownership by 2% to 11,030 units (SEC Form 4)
- Bernstein resumed coverage on Illumina with a new price target
- Chief Legal Officer Davies Scott M sold $110,700 worth of shares (615 units at $180.00), decreasing direct ownership by 3% to 20,953 units (SEC Form 4)
- Director Skovronsky Daniel was granted 1,674 shares (SEC Form 4)
- SEC Form 3 filed by new insider Skovronsky Daniel
- Illumina Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
Latest TRUP
- Trupanion Announces Second Quarter 2026 Earnings Release and Conference Call
- Chief Operating Officer Gallagher John R sold $10,926 worth of shares (431 units at $25.35) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 32,634 units (SEC Form 4)
- SEC Form 144 filed by Trupanion Inc.
- Trupanion to Participate in Virtual Fireside Chat with Piper Sandler
- Trupanion Announces Winners of the 2026 Veterinary Appreciation Day® Awards
- Trupanion Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- EVP, North Am & Vet Strategy Weinrauch Steve exercised 8,500 shares at a strike of $15.46 and sold $146,828 worth of shares (6,674 units at $22.00), increasing direct ownership by 2% to 78,062 units (SEC Form 4)
- Amendment: SEC Form 4 filed by EVP, Trupanion International Wheeler Simon
- Amendment: SEC Form 4 filed by EVP, Trupanion International Wheeler Simon
- Chief Operating Officer Gallagher John R sold $78,153 worth of shares (3,603 units at $21.69) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 33,065 units (SEC Form 4)